A $20 Pain Cream Billed at $1,920: Allstate Files 3 RICO Suits Against NY Pharmacies

A single tube of prescription pain ointment billed at up to $1,920.90, versus an over-the-counter equivalent costing under $20, sits at the center of one of the most striking no-fault auto insurance fraud cases of 2026.

Insurance Business reported that Allstate filed three separate federal lawsuits on the same day, September 30, 2026, targeting three New York pharmacies it accuses of running identical billing schemes against its no-fault policyholders. The complaints, filed in the US District Court for the Eastern District of New York, allege more than $414,000 in fraudulent paid claims and seek to void an additional $703,000 in outstanding bills. According to Insurance Business, the cases are brought under RICO, the federal racketeering statute, which opens the door to triple damages if the allegations are proven in court.

The Save Max Quote Index, drawn from 3.3 million+ real quote requests, consistently shows New York auto insurance ranking among the most expensive in the nation, and cases like this one help explain exactly why.

A $1,900 tube of cream, and three federal lawsuits filed the same day

The pricing contrast is almost impossible to ignore. Allstate's complaints describe prescription Lidocaine 5% ointment billed at up to $1,920.90 for 250 grams by one pharmacy, and up to $1,907.50 per prescription by another. Sitting on a drugstore shelf nearby: Aspercreme, Icy Hot, and Bengay, products containing lidocaine at 4% concentration, available for under $20 for a 133-gram tube.

That gap, according to the filings, was not accidental. It was the financial engine of an alleged scheme involving three separate New York pharmacies, each accused of billing Allstate for grossly overpriced topical medications dispensed through kickback arrangements with no-fault auto clinics.

The three defendants are Narrow Pharmacy Inc. in Brooklyn, Redfern Drugs Inc. in Far Rockaway, and Punjab Rx Pharmacy Inc. in South Richmond Hill. All three complaints were filed simultaneously on September 30, 2026, in the US District Court for the Eastern District of New York, a coordinated legal strike targeting the pharmacy end of New York's no-fault pipeline.

Allstate is pursuing RICO charges alongside New York common-law fraud claims. Because RICO allows for triple damages, the financial exposure for the defendants could substantially exceed the dollar figures already cited in the filings.

How the alleged billing scheme worked across all three pharmacies

Here is the playbook Allstate describes, which it says was consistent across all three defendants.

First, a patient involved in a car accident is referred to a no-fault medical clinic in the New York metro area. That clinic, as a matter of what the filings call "pattern, practice and protocol," prescribes expensive topical Lidocaine 5% ointment and a selection of oral medications, regardless of whether the individual patient actually needed them. No documentation was produced explaining why the pricier prescription product was necessary over a cheap over-the-counter alternative, "even for minor sprains," the complaints state.

Second, the prescription is routed to one of the defendant pharmacies, which fills it and bills Allstate directly.

Third, and this is the part that makes the scheme self-sustaining, the clinics and pharmacies allegedly maintained "illicit financial relationships and/or compensation arrangements." The referral network was not incidental. None of the three pharmacies advertised to the public or operated a website. Every patient they saw came through clinic referrals.

Atlantic Medical & Diagnostic P.C. appears by name as a prescribing source in both the Narrow Pharmacy and Redfern Drugs complaints. The filings note that prior litigation against that clinic by multiple no-fault carriers, including Allstate and State Farm, had already resulted in courts granting "stays and preliminary injunctions" after finding "serious questions concerning the merits of the fraud allegations."

Breaking down the numbers: what Allstate says it paid and what it wants back

Redfern Drugs accounts for the largest single claim, with more than $233,000 in paid claims alone. When you add the unpaid claims across all three defendants, the total exposure climbs past $1.1 million before any RICO multiplier is applied.

Punjab Rx's alleged billing adds particular detail to the financial picture. Beyond Lidocaine 5% ointment at $1,907.50 per prescription, that complaint also targets billing for Cyclobenzaprine Hydrochloride 15mg tablets, a muscle relaxer, at $2,721.62 per prescription.

The red flags embedded in the patient records

Allstate's complaints do not rely solely on the pricing disparity. They point to specific billing irregularities visible in the patient records themselves.

In the Narrow Pharmacy filing, one patient received a prescription for Lidocaine 5% ointment just three days after their car accident, with no documented assessment of whether an over-the-counter product would have sufficed. Another patient received the same prescription less than a week post-collision. The examination reports accompanying these prescriptions were described as "boilerplate" and "designed to limit the prescribing providers' prescriptions to a predetermined treatment protocol."

The Punjab Rx complaint adds a distinct red flag: overlapping prescriptions. The pharmacy allegedly issued new 30-day supplies before previous ones would have been exhausted, billing "in order to maximize profits without regard for patient care," according to the filing.

Punjab Rx also allegedly billed for Diclofenac Sodium 2% solution, which the complaint says "does not have any proven efficacy or safety in the treatment of musculoskeletal injuries such as sprains or strains."

Taken together, the pattern SIU teams are trained to spot looks like this:

• High-concentration topical ointments prescribed as first-line treatment within days of an accident
• No documented rationale for choosing prescription over over-the-counter alternatives
• Boilerplate examination reports with predetermined outcomes
• Overlapping refill schedules that outpace plausible consumption
• Pharmacies with no public-facing presence, operating exclusively through clinic referrals
• A narrow menu of high-margin medications dispensed across a large volume of accident patients

Why New York's no-fault system keeps producing these cases

New York's no-fault auto insurance framework requires insurers to pay medical bills submitted by providers, including pharmacies, promptly and without requiring proof of fault in the underlying accident. That structure, designed to ensure injured people get care quickly, also creates a billing pipeline that bad actors have repeatedly exploited.

The mechanics are straightforward. A provider bills a no-fault carrier. The carrier has limited time to challenge the claim before being required to pay. Fraudulent providers can move faster than fraud detection systems, collecting payments before any investigation is complete.

New Jersey auto insurance operates under a similar no-fault framework, and fraud researchers have documented comparable billing schemes emerging there as well. The New York metro area, however, produces a disproportionate share of these cases, partly because of the density of providers, accident volumes, and the size of the insured population.

Two of the three pharmacies named in these suits, Narrow Pharmacy and Punjab Rx, were formed in late 2023 and registered with the New York State Office of Professions in early 2024. That timing suggests entities purpose-built for this kind of billing activity, entering the market during a period when no-fault fraud enforcement remained active but not always fast enough to prevent initial payouts.

Redfern Drugs, the defendant with the largest alleged paid-claim exposure, has been registered since 2009, a reminder that these schemes are not always the work of newly created shell operations.

What this means for you

No-fault auto insurance fraud does not stay contained to courtrooms and SIU spreadsheets, it reaches your renewal notice. Review any explanation of benefits you receive after an accident carefully, and report prescriptions or treatments you never requested to your insurer's fraud hotline. If you are shopping for coverage in a high-fraud state, use the SMQI to benchmark quotes across carriers and identify whether your current rate reflects the fraud risk built into your zip code. Drivers in Pennsylvania and Connecticut, neighboring states with their own no-fault or hybrid frameworks, should also factor regional fraud exposure into their coverage decisions.

Where the cases stand and what comes next

All three complaints were filed September 30, 2026. No court has ruled on the merits of any of them, and the allegations against Narrow Pharmacy Inc., Redfern Drugs Inc., and Punjab Rx Pharmacy Inc. remain untested.

If the cases proceed and Allstate prevails on its RICO claims, the financial consequences for the defendants extend well beyond reimbursement. RICO's triple-damages provision would multiply the paid-claim recovery, and the court orders Allstate is seeking would also declare the more than $703,000 in outstanding bills legally void, meaning those unpaid claims could never be collected.

Each complaint brings three distinct categories of legal claims: RICO for triple damages, New York common-law fraud for both compensatory and punitive damages, and a declaratory judgment confirming Allstate has no payment obligation on the outstanding bills.

The outcome of these cases will matter beyond the individual defendants. A successful RICO judgment against pharmacy-end no-fault fraud would strengthen the legal architecture that SIU teams rely on when challenging similar pipelines, and could inform how carriers approach claim challenges in future cases involving the same prescribing clinics, the same medication protocols, and the same referral-only business model.

FAQ

About Brooke Grissom

Brooke Grissom is an Independent Insurance Analyst at Save Max Auto, licensed in Property & Casualty and Health insurance. She covers data-driven market trends, cross-state premium comparisons, and carrier financial analysis. Read more from Brooke Grissom →

Edited by Aaren Ramon.

Methodology

This article is grounded in the source linked above. Save Max Auto data points referenced here are drawn from the Save Max Quote Index (SMQI), a proprietary instrument reflecting 3,364,317 real consumer quote requests submitted to savemaxauto.com. State and carrier rankings reflect the lifetime dataset; year-over-year shifts reflect a rolling 12-month window. The index is refreshed monthly. External authority figures referenced (NAIC, NHTSA, state regulators) reflect the most recent public data releases available at time of writing.

Sources

• Primary source: Insurance Business, "$1,900 for pain cream sold for $20: Allstate files triple RICO suits"